Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer
Titel:
Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer
Auteur:
Scagliotti, Giorgio V. Novello, Silvia Schiller, Joan H. Hirsh, Vera Sequist, Lecia V. Soria, Jean-Charles von Pawel, Joachim Schwartz, Brian Von Roemeling, Reinhard Sandler, Alan B.